CJC 1295W/Ipamorelin ( NO DAC)

CJC-1295 (No DAC) combined with Ipamorelin is a research peptide blend studied for its potential role in stimulating endogenous growth hormone (GH) release. In pre-clinical studies, this combination has been used to explore synergistic effects on the GH axis, with CJC-1295 supporting GHRH receptor activity and Ipamorelin acting on ghrelin receptors (GHRP family). Researchers have examined this pairing for its potential relevance to metabolic function, cellular recovery, and hormone regulation under controlled laboratory conditions.

Disclaimer:

This product is provided for laboratory research use only. It is not approved for human consumption, clinical use, or therapeutic application.